A Novel Probiotic-antibiotic Combination to Prevent Recurrent Urinary Tract Infections

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 2, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions

Recurrent Uti

Interventions

DRUG

Saccharomyces Boulardii 250 MG [Florastor]

All patients will get the probiotic to be taken daily. If UTI occurs with a sensitive pathogen, we will treat with ciprofloxacin

Trial Locations (1)

RECRUITING

Lurie Children's Hospital, Chicago

All Listed Sponsors

lead

Ann & Robert H Lurie Children's Hospital of Chicago

OTHER